MILANO (AIMnews.it) – Kolinpharma has signed a scientific research contract with the Department of Chemistry, Technologies and Pharmacy of the University of Rome ‘La Sapienza’. The agreement provides for the development of an innovative and original technological platform aimed at studying the active ingredients with the aim of creating patents. Moreover, thanks to the agreement signed with Nutrilinea, the number of companies dealing with the industrial production of the Kolinpharma nutraceutical brand rises to three. The agreement was signed with a view to diversifying the producers’ portfolio.